Location History:
- Kusnacht, Zurich, CH (1976)
- Kuesnacht, Zurich, CH (1976)
- Kusnacht, CH (1976 - 1997)
Company Filing History:
3 out of 6,850 
3 out of 825 
1 out of 166 
Years Active: 1976-1997
Title: Albert Eschenmoser: A Pioneer in Nucleoside Chemistry
Introduction
Albert Eschenmoser is a distinguished inventor known for his significant contributions to the field of nucleoside chemistry. He is based in Kusnacht, Switzerland, and holds a total of 9 patents. His work has had a profound impact on the development of antiviral agents and biologically active oligonucleotides.
Latest Patents
Eschenmoser's latest patents include innovative compounds such as carbocyclic nucleosides containing bicyclic rings. These compounds, described in his patents, can be utilized as antiviral active ingredients or for the preparation of biologically active oligonucleotides. The specific formulae outlined in his patents detail the structural components that contribute to their efficacy in medicinal applications.
Career Highlights
Throughout his career, Albert Eschenmoser has worked with prominent companies, including Ciba-Geigy Corporation and Firmenich SA. His expertise in chemistry and innovation has led to numerous advancements in the pharmaceutical industry, particularly in the area of nucleoside research.
Collaborations
Eschenmoser has collaborated with notable colleagues such as Karl-Heinz Altmann and Rene Imwinkelried. These partnerships have fostered a collaborative environment that has enhanced the development of new chemical compounds and therapeutic agents.
Conclusion
Albert Eschenmoser is a remarkable inventor whose work in nucleoside chemistry continues to influence the field. His patents and collaborations reflect his dedication to advancing scientific knowledge and improving health outcomes through innovative research.